Regent’s Park appoints Dr. Peter Schofield as its Clinical Director

LONDON, United Kingdom, 14 December, 2009: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has appointed Dr. Peter Schofield as its Clinical Director.

Dr. Schofield is currently a Consultant Cardiologist at Addenbrookes & Papworth Hospitals, Cambridge.
He was appointed a Consultant Cardiologist in 1989 and is currently the Clinical Chairman of the Anglia Cardiac Network.  The network is responsible for the strategic direction and provision of cardiac services within Cambridgeshire, Norfolk and Suffolk.

Dr. Schofield holds a National Clinical Excellence Award – currently level 10. His subspecialty interest is in percutaneous coronary intervention procedures. His experience in this area covers some 25 years of practice. In recent years, he has carried out up to 750 procedures per year with a success rate of greater than 98%.

Dr. Schofield has published over 150 research papers in peer reviewed journals.  He has also written 5 books on cardiovascular disease. His major research interest over the years has been the evaluation of new technologies in the cardiovascular field.  Most of this work has been published in peer reviewed journals. As a result of this, many techniques have now been incorporated into routine clinical practice.

Dr. Schofield was the Secretary of the British Cardiac Society (BCS) for a period of 4 years and has been a Council Member of the British Cardiovascular Intervention Society (BCIS). He is a Fellow of the Royal College of Physicians, Fellow of the American College of Cardiology and Fellow of the European Society of Cardiology.

“I am delighted to welcome Dr. Schofield to our company.” said Dr. Ohri, Chairman and Chief Executive Officer of Regent’s Park. “He brings immense clinical and managerial experience that will be beneficial as we continue to develop patient-focused services, grow through joint ventures and expand our business activities across the United Kingdom.”  Dr. Ohri added: “His wide ranging expertise derived from the NHS, academia and industry, as well as his strategic work at a national level with BCS and BCIS, has allowed him to understand both the complexities and challenges within the cardiovascular services sector. It means he is ideally placed to provide our company with strong clinical leadership on future cardiovascular trends, as well as the organisation and structure of next generation cardiovascular programs.”

Dr. Schofield said: “I am very pleased to become the Clinical Director of a company with such high standards for delivering quality cardiovascular care.” He added: “Regent’s Park is developing a strong reputation within the cardiovascular services sector, and its proven track record of developing cost-effective, innovative partnerships with the NHS makes it a company with excellent growth opportunities.”

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 23,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

DOWNLOAD PRESS RELEASE